中国交建(01800.HK)海德公司拟向信科集团增发2675万股
格隆汇6月18日丨中国交建(01800.HK)发布公告,2019年6月18日,公司召开第四届董事会第二十三次会议,审议通过《关于中交海德公司股权整合所涉关联交易的议案》。
同意公司下属的上海中交海德交通科技股份有限公司(简称海德公司)向信科集团增发2675万股股份,交易对价为3769.52万元,增资完成后,信科集团将持有海德公司56.02%的股份。
同意公司下属的中交第一公路勘察设计研究院有限公司收购海德公司所持上海城兴市政工程设计有限公司55%股权,交易对价为472.25万元。
信科集团为公司控股股东中交集团的下属公司,该事项构成关联交易,关联交易金额共计约为4241.77万元人民币。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.